The global market for oncology therapeutic medicines will reach as much as $200 billion by 2022, averaging 10 to 13 percent growth over the next five years, with the U.S. market reaching as much as $100 billion by 2022, averaging 12 to 15 percent growth.
Spending on cancer drugs has doubled over the past five years.
The average cost of a new drug released in 2017 was $150,000.
Cancer drug costs are expected to double again by 2022.
While cancer rates and rates of death have been steadily dropping, drug spending will go up.